|
TNRC6C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.41789929692027E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.66850027922317E-10 |
| Normal-vs-Stage2 |
1.143420E-03 |
| Normal-vs-Stage3 |
4.39409619801268E-11 |
| Normal-vs-Stage4 |
1.6972000027593E-08 |
| Stage1-vs-Stage2 |
1.284570E-01 |
| Stage1-vs-Stage3 |
4.849800E-02 |
| Stage1-vs-Stage4 |
5.089600E-02 |
| Stage2-vs-Stage3 |
9.017600E-03 |
| Stage2-vs-Stage4 |
1.528200E-02 |
| Stage3-vs-Stage4 |
6.639200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.13040021787469E-10 |
| Normal-vs-AfricanAmerican |
4.139000000003E-05 |
| Normal-vs-Asian |
1.80139999994555E-06 |
| Caucasian-vs-AfricanAmerican |
6.954600E-01 |
| Caucasian-vs-Asian |
4.411200E-01 |
| AfricanAmerican-vs-Asian |
4.107200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.24629999653791E-08 |
| Normal-vs-Female |
7.5434991586576E-11 |
| Male-vs-Female |
5.570400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.24329999628969E-08 |
| Normal-vs-Age(41-60Yrs) |
2.5398000369492E-09 |
| Normal-vs-Age(61-80Yrs) |
2.02179994968077E-09 |
| Normal-vs-Age(81-100Yrs) |
3.037600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.658000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.587630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.186000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.447000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.985000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.207600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.6704995426694E-10 |
| Classical-VS-Follicular |
7.542800E-01 |
| Classical-VS-Other |
3.066000E-01 |
| Classical-VS-Normal |
1.39920000030713E-08 |
| Tall-VS-Follicular |
1.17769999974371E-07 |
| Tall-VS-Other |
5.518200E-02 |
| Tall-VS-Normal |
4.44089209850063E-16 |
| Follicular-VS-Other |
3.824000E-01 |
| Follicular-VS-Normal |
8.9017000004521E-07 |
| Other-VS-Normal |
2.355600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.57060000455434E-08 |
| Normal-vs-N1 |
5.06920000420408E-08 |
| N0-vs-N1 |
1.700160E-01 |
|
|
